Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization

Clinical Cancer Research

Volumn 14, Issue 16, 2008, Pages 5270-5283

  Walker, Edwin B ^a,c   Haley, Daniel ^a   Petrausch, Ulf ^a   Floyd, Kevin ^a   Miller, William ^a   Sanjuan, Nelson ^a   Alvord, Greg ^b   Fox, Bernard A ^a   Urba, Walter J ^a  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 100; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; CANCER VACCINE; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN;

ARTICLE; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; MELANOMA; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; RANDOMIZED CONTROLLED TRIAL; SKIN TUMOR;

CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MELANOMA; MEMBRANE GLYCOPROTEINS; PHENOTYPE; SKIN NEOPLASMS;

EID: 52649084694     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0022     Document Type: Article

References (67)

1. Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998;4:321 -7.
2. Rosenberg SA, Sherry RM, Morton KE, et al. Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+Tcells in patients with melanoma. J Immunol 2005;175: 6169-76.
3. Ayyoub M, Zippelius A, Pittet MJ, et al. Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by Tcells-1. Clin Cancer Res 2003;9:669-77.
4. Speiser DE, Romero P. Toward improved immuno-competence of adoptively transferred CD8+ Tcells. J Clin Invest 2005;115:1467-9.
5. Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P. Human T cell responses against melanoma. Annu Rev Immunol 2006;24:175-208.
6. Rosenberg SA.Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004;10:909-15.
7. Klebanoff CA, Gattinoni L.Torabi-Parizi P, et al. Central memory self/tumor-reactive CD8+ Tcells confer superior antitumor immunity compared with effector memoryTcells. Proc Natl Acad Sci U S A 2005;102: 9571 -6.
8. Roberts AD, Ely KH, Woodland DL Differential contributions of central and effector memory T cells to recall responses. J Exp Med 2005;202:123-33.
9. Klebanoff CA, Gattinoni L Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 2006;211:214-24.
10. Powell DJ, Jr., Rosenberg SA. Phenotypic and functional maturation of tumor antigen-reactive CD8+ T lymphocytes in patients undergoing multiple course peptide vaccination. J Immunother 2004;27: 36-47.
11. Smith JW II, Walker EB, Fox BA, et al. Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses. J Clin Oncol 2003;21: 1562-73.
12. Walker EB, Haley D, Miller W, et al. gp100(209-2M) peptide immunization of human lymphocyte antigen- A2+ stage l-lll melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ Tcells. Clin Cancer Res 2004;10: 668-80.
13. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001;410:106-11.
14. KuijpersTW.Vossen MT, Gent MR, et al. Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV. J Immunol 2003;170:4342 - 8.
15. van Leeuwen EM, de Bree GJ, ten Berge IJ, van Lier RA. Human virus-specific CD8+ Tcells: diversity specialists. Immunol Rev 2006;211:225-35.
16. Meijer SL, Dols A, Jensen SM, et al. Induction of circulating tumor-reactive CD8+ Tcells after vaccination of melanoma patients with the gp100 209-2M peptide. J Immunother 2007;30:533-43.
17. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004;4:648-55.
18. Bagwell CB. Hyperlog-a flexible log-like transform for negative, zero, and positive valued data. Cytometry A 2005;64:34-42.
19. Petrausch U, Haley D, Miller W, etal. Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter data. Cytometry A 2006;69:1162-73.
20. Tung JW, Parks DR, Moore WA, Herzenberg LA. New approaches to fluorescence compensation and visualization of FACS data. Clin Immunol 2004;110: 277-83.
21. Saeed Al, SharovV, White J, et al.TM4: a free, open- source system for microarray data management and analysis. Biotechniques 2003;34:374- 8.
22. Gentleman RC, Carey VJ, Bates DM, et al. Biocon- ductor: open software development for computational biology and bioinformatics. Genome Biol 2004:5: R80.
23. Masopust D, Ha SJ.VezysV, Ahmed R. Stimulation history dictates memory CD8 Tcell phenotype: implications for prime-boost vaccination. J Immunol 2006; 177:831 -9.
24. Busch DH, Pamer EG. Tcell affinity maturation by selective expansion during infection. J Exp Med 1999;189:701-10.
25. Kedl RM, Schaefer BC, Kappler JW, Marrack P. Tcells down-modulate peptide-MHC complexes on APCs in vivo. Nat Immunol 2002;3:27-32.
26. Rodriguez F, Harkins S, Slifka MK, Whitton JL. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by γ interferon. J Virol 2002;76: 4251 -9.
27. Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) Tcells without selection of higher affinity TCR. Nat Immunol 2001;2:711 -7.
28. Cawthon AG, Alexander-Miller MA. Optimal coloc- alization of TCR and CD8 as a novel mechanism for the control of functional avidity. J Immunol 2002;169: 3492-8.
29. Veiga-Fernandes H.Walter U, Bourgeois C, McLean A, Rocha B Response of naive and memory CD8+ Tcells to antigen stimulation in vivo.Nat Immunol 2000;1:47-53.
30. Rocha B.Tanchot C. TheTower of Babel of CD8+ T-cell memory: known facts, deserted roads, muddy waters, and possible dead ends. Immunol Rev 2006; 211:182-96.
31. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
32. van Baarle D, Kostense S, van Oers MH, Hamann D, Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.Trends Immunol 2002;23:586-91.
33. Kern F, Khatamzas E, Surel I, et al. Distribution of human CMV-specific memory Tcells among the CD8pos. Subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol 1999;29:2908-15.
34. Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003;101:4260-6.
35. Tomiyama H, MatsudaT.Takiguchi M. Differentiation of human CD8(+) Tcells from a memory to memory/ effector phenotype. J Immunol 2002;168:5538-50.
36. Takata H.Takiguchi M. Three memory subsets of human CD8+ Tcells differently expressing three cytolytic effector molecules. J Immunol 2006;177:4330-40.
37. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memoryT lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-12.
38. Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ Tcells. Blood 2003;101:2711-20.
39. Faint JM, Annels NE, Curnow SJ, et al. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics. J Immunol 2001;167: 212-20.
40. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 Tcell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002;169:1984-92.
41. Chen G, Shankar P, Lange C, et al. CD8 Tcells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001;98: 156-64.
42. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 Tcell subsets. Nat Immunol 2003;4:225-34.
43. Marzo AL, Klonowski KD, Le Bon A, et al. Initial Tcell frequency dictates memory CD8+ Tcell lineage commitment. Nat Immunol 2005;6:793-9.
44. van Faassen H, Saldanha M, Gilbertson D, etal. Reducing the stimulation of CD8+ Tcells during infection with intracellular bacteria promotes differentiation primarily into a central (CD62LhighCD44high) subset. J Immunol 2005;174:5341-50.
45. de Bree GJ, Heidema J, van Leeuwen EM, et al. Respiratory syncytial virus-specific CD8+ memory Tcell responses in elderly persons. J Infect Dis 2005; 191:1710-8.
46. He XS, Mahmood K, Maecker HT, et al. Analysis of the frequencies and of the memory Tcell phenotypes of human CD8+ Tcells specific for influenza Aviruses. J Infect Dis 2003;187:1075-84.
47. Wallace DL, Zhang Y, Ghattas H, et al. Direct measurement of Tcell subset kinetics in vivo in elderly men and women. J Immunol 2004;173:1787-94.
48. Bchmann MF, Wolint P, Schwarz K, Jager P, Oxenius A. Functional properties and lineage relationship of CD8+ Tcell subsets identified by expression of IL-7 receptor α and CD62L. J Immunol 2005;175: 4686-96.
49. Veiga-Fernandes H, Rocha B. High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division. Nat Immunol 2004;5:31 -7.
50. Hernandez J, Aung S, Marquardt K, Sherman LA. Uncoupling of proliferative potential and gain of effector function by CD8(+) Tcells responding to self-antigens. J Exp Med 2002;196:323-33.
51. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatoryTcells in immunological tolerance to self and non-self. Nat Immunol 2005;6: 345-52.
52. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71 -8.
53. Barber DL,Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682-7.
54. Agarwal S, Rao A. Modulation of chromatin structure regulates cytokine gene expression during Tcell differentiation. Immunity 1998;9:765-75.
55. Fitzpatrick DR, Shirley KM, Kelso A. Cutting edge: stable epigenetic inheritance of regional IFN-γ promoter demethylation in CD44highCD8+ T lymphocytes. J Immunol 1999;162:5053-7.
56. Ouyang W, Lohning M, Gao Z, et al. State- independent GATA-3 autoactivation directs IL-4- independent Th2 development and commitment. Immunity 2000:12:27-37.
57. Pearce EL, Mullen AC, Martins GA, et al. Control of effector CD8+ Tcell function by the transcription factor Eomesodermin. Science 2003;302:1041 -3.
58. Intlekofer AM.Takemoto N, Wherry EJ, et al. Effector and memory CD8+ Tcell fate coupled byT-bet and eomesodermin. Nat Immunol 2005;6:1236-44.
59. Janssen EM, Droin NM, Lemmens EE, et al. CD4+ T-cell help controls CD8+ T-cell memory viaTRAIL- mediated activation-induced cell death. Nature 2005; 434:88-93.
60. Romero P, Zippelius A, Kurth I, et al. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 2007;178:4112-9,
61. Hathcock KS, Kaech SM, Ahmed R, Hodes RJ. Induction of telomerase activity and maintenance of telomere length in virus-specific effector and memory CD8+Tcells. J Immunol 2003;170:147-52.
62. Hamann D, Kostense S,Wolthers KC, et al. Evidence that human CD8+CD45RA+CD27" cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999;11:1027-33.
63. Pitcher CJ, Hagen SI, Walker JM, et al. Development and homeostasis of Tcell memory in rhesus macaque. J Immunol 2002;168:29-43.
64. Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 Tcells do not develop during chronic viral infection. Proc Natl Acad Sci U S A 2004; 101:16004 - 9.
65. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ Tcells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8: 379-85.
66. Mortarini R, Piris A, Maurichi A, etal. Lack of terminally differentiated tumor-specific CD8+ Tcells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res 2003:63: 2535-45.
67. Inokuma M, dela Rosa C, Schmitt C, et al. Functional Tcell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature. J Immunol 2007,179.2627-33.